000			01956 a2200577 4500
005			20250517174528.0
264		0	_c20180604
008			201806s 0 0 eng d
022			_a2047-9980
024	7		_a10.1161/JAHA.117.006508 _2doi
040			_aNLM _beng _cNLM
100	1		_aBadri, Marwan
245	0	0	_aPrecatheterization Use of P2Y _h[electronic resource]
260			_bJournal of the American Heart Association _cSep 2017
500			_aPublication Type: Journal Article; Observational Study
650	0	4	_aAged
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aBlood Transfusion
650	0	4	_aCardiac Catheterization _xadverse effects
650	0	4	_aChi-Square Distribution
650	0	4	_aCoronary Angiography _xadverse effects
650	0	4	_aCoronary Artery Bypass _xadverse effects
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNon-ST Elevated Myocardial Infarction _xblood
650	0	4	_aOdds Ratio
650	0	4	_aPlatelet Aggregation Inhibitors _xadministration & dosage
650	0	4	_aPredictive Value of Tests
650	0	4	_aPropensity Score
650	0	4	_aProportional Hazards Models
650	0	4	_aPurinergic P2Y Receptor Antagonists _xadministration & dosage
650	0	4	_aReceptors, Purinergic P2Y12 _xblood
650	0	4	_aRegistries
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTime-to-Treatment
650	0	4	_aTreatment Outcome
700	1		_aAbdelbaky, Amr
700	1		_aLi, Shuang
700	1		_aChiswell, Karen
700	1		_aWang, Tracy Y
773	0		_tJournal of the American Heart Association _gvol. 6 _gno. 9
856	4	0	_uhttps://doi.org/10.1161/JAHA.117.006508 _zAvailable from publisher's website
999			_c27594013 _d27594013